全文获取类型
收费全文 | 8378篇 |
免费 | 513篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 585篇 |
妇产科学 | 99篇 |
基础医学 | 942篇 |
口腔科学 | 141篇 |
临床医学 | 662篇 |
内科学 | 1463篇 |
皮肤病学 | 160篇 |
神经病学 | 410篇 |
特种医学 | 204篇 |
外科学 | 1448篇 |
综合类 | 195篇 |
一般理论 | 1篇 |
预防医学 | 504篇 |
眼科学 | 238篇 |
药学 | 901篇 |
中国医学 | 42篇 |
肿瘤学 | 819篇 |
出版年
2023年 | 53篇 |
2022年 | 87篇 |
2021年 | 265篇 |
2020年 | 147篇 |
2019年 | 180篇 |
2018年 | 274篇 |
2017年 | 199篇 |
2016年 | 245篇 |
2015年 | 231篇 |
2014年 | 345篇 |
2013年 | 423篇 |
2012年 | 619篇 |
2011年 | 616篇 |
2010年 | 369篇 |
2009年 | 261篇 |
2008年 | 454篇 |
2007年 | 428篇 |
2006年 | 380篇 |
2005年 | 339篇 |
2004年 | 323篇 |
2003年 | 290篇 |
2002年 | 208篇 |
2001年 | 191篇 |
2000年 | 156篇 |
1999年 | 159篇 |
1998年 | 57篇 |
1997年 | 47篇 |
1996年 | 42篇 |
1995年 | 43篇 |
1992年 | 101篇 |
1991年 | 73篇 |
1990年 | 84篇 |
1989年 | 91篇 |
1988年 | 67篇 |
1987年 | 68篇 |
1986年 | 67篇 |
1985年 | 84篇 |
1984年 | 64篇 |
1983年 | 56篇 |
1980年 | 33篇 |
1979年 | 70篇 |
1978年 | 39篇 |
1977年 | 38篇 |
1976年 | 48篇 |
1975年 | 66篇 |
1974年 | 38篇 |
1973年 | 60篇 |
1971年 | 41篇 |
1970年 | 32篇 |
1969年 | 39篇 |
排序方式: 共有8916条查询结果,搜索用时 15 毫秒
991.
Vaughan MD Rowland CC Tong X Srivastava DK Hale GA Rochester R Kaste SC 《Bone marrow transplantation》2005,36(8):725-729
Our purpose was to describe the types and frequencies of altered dental development in pediatric patients following bone marrow transplantation (BMT). A retrospective review of the medical records and panoramic radiographs of all patients who underwent BMT at St Jude Children's Research Hospital between 1990 and 2000, for whom pre-BMT and post-BMT dental examination and panoramic radiography records were available, is presented. All patients were treated on institutional protocols. We recorded patient demographics and radiographic evidence of microdontia, hypodontia, taurodontia, root stunting, caries, enamel pearls, dental restorations/extractions and pulpal calcification. The 99 patients identified (52 males, 47 females) had a median age of 13.5 years (range, 3.4-25.9 years) at the time of BMT. In all, 73 were Caucasian, 15 were African-American, and 11 were of other races. The frequency of radiographically evident root stunting in permanent teeth was significantly increased after BMT (P<0.001), but there was no significant change in the frequency of other dental abnormalities after BMT. Dental abnormalities are prevalent in survivors of childhood BMT, but only root stunting appeared to progress with BMT. 相似文献
992.
The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration 总被引:4,自引:0,他引:4
BACKGROUND: The use of low-molecular weight heparin (LMWH) during percutaneous coronary intervention (PCI) has been limited by the presumed inability to monitor its anticoagulant effect using bedside assays. OBJECTIVES: This study was designed to compare the dose-response of enoxaparin, dalteparin and unfractionated heparin (UFH) on the activated clotting time (ACT), and to determine whether the ACT or aPTT can be used to monitor intravenous (IV) low molecular weight heparin (LMWH). METHODS: A total of 130 patients undergoing cardiac catheterization were assigned to intravenous enoxaparin 0.5 mg/kg, dalteparin 50 international units/kg or UFH 50 units/kg. Of the 130 patients, 46 (35%) underwent PCI, all of whom received a glycoprotein (GP) IIb/IIIa inhibitor. We measured ACT, activated partial thromboplastin time (aPTT) and plasma anti-Xa levels after serial sampling. RESULTS: Both enoxaparin and dalteparin induced a significant rise in the ACT and aPTT, with an ACT dose-response approximately one-half the magnitude of that obtained using UFH. The time course of changes in the ACT and aPTT after administration of enoxaparin and dalteparin was virtually identical, with a return to baseline at approximately 2 hours. The enoxaparin and dalteparin-treated patients successfully underwent PCI with no major hemorrhagic complications. CONCLUSIONS: The ACT is equally sensitive to IV enoxaparin and dalteparin. These data support an ACT-guided strategy for intravenously administered LMWH during PCI. Additional studies with larger patient populations may be indicated to determine the ideal target ACT for LMWH in PCI. 相似文献
993.
994.
995.
996.
Can we identify vulnerable patients at risk for ST-segment elevation myocardial infarction based on their clinical characteristics? 总被引:1,自引:0,他引:1
Chou ET Minutello RM Parikh M Bergman G Chiu Wong S Hong MK 《Coronary artery disease》2004,15(8):467-469
OBJECTIVE: Coronary artery plaque rupture is a sudden, unpredictable event leading to acute coronary syndrome. Thus far, there is no clinical characteristic to distinguish the patients at risk for acute myocardial infarction from those with more stable coronary artery disease. The purpose of this study was to identify clinical predictors of first ST-segment elevation myocardial infarction (STEMI). METHODS: We retrospectively compared 116 consecutive patients presenting with their first STEMI for primary angioplasty and 216 ambulatory patients with stable angina requiring their first coronary intervention. RESULTS: Patients with STEMI were younger, more likely to be smokers, but less likely to have hypertension or hypercholesterolemia. Diabetes was present equally between the two groups. Cardioprotective medication usage, such as aspirin and statin, was much lower among patients presenting with their first STEMI. CONCLUSIONS: Thus, patients with STEMI presumably from plaque rupture have fewer traditional risk factors compared with patients with stable angina. Identifying these vulnerable patients at risk for plaque rupture may enable early institution of cardioprotective pharmacotherapy to prevent their first acute coronary syndrome occurrence. 相似文献
997.
998.
999.
1000.